Information Provided By: 
Fly News Breaks for April 28, 2015
TEVA, MYL
Apr 28, 2015 | 07:46 EDT
Oppenheimer believes that Mylan's (MYL) rejection of Teva's (TEVA) proposed takeover was more than just posturing, since Mylan's chairman used "a highly critical tone" when talking about the Israeli company and expressed skepticism about its outlook. Oppenheimer says that Teva should not prolong the process, and the firm believes that Teva will now start evaluating other options.
News For MYL;TEVA From the Last 2 Days
There are no results for your query MYL;TEVA
